COMMUNIQUÉS West-GlobeNewswire

Aurora Spine Corporation Announces Record Second Quarter Financial Results
29/08/2025
- Company to host conference call Tuesday, September 2nd at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aurora Spine [...]
SRx Health Solutions Cancels an Additional 350,000 Shares, Increasing the Total Number of Shares Canceled to Over 19 Million
29/08/2025
All legal options remain under consideration regarding the actions of former SRx Canada officers TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
29/08/2025
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Cantor [...]
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights
29/08/2025
US FDA 510(k) submission remains on track for calendar Q3 2025 Successful validation testing of Novasight Hybrid ™ system with key opinion leaders Recent academic publications underscore importance of intravascular [...]
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
29/08/2025
IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat [...]
Arvinas to Participate in Upcoming Investor Conferences
29/08/2025
NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that [...]
Alumis to Participate in Upcoming September Investor Conferences
29/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today [...]
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
29/08/2025
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; [...]
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale
29/08/2025
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale NANTES, France - 29 août 2025, 8h00 [...]
Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India
29/08/2025
Pratteln, Switzerland , 29 August , 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in [...]
PCI Biotech half-year interim 2025 report
29/08/2025
Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation. Highlights review Operations PCI Biotech decided on [...]
Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil®
29/08/2025
Financial Results and Operational Update for the Full Year Ended June 30, 2025 NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for [...]
Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering
29/08/2025
TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCardia Total [...]
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
29/08/2025
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of [...]
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
29/08/2025
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), [...]
UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results
29/08/2025
Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical [...]
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
28/08/2025
– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Privia Health [...]
Cascade Prodrug Inc. Appoints Industry Veterans Manuel (Manny) Litchman and Andres Gutierrez to Board of Directors
28/08/2025
EUGENE, Ore., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cascade Prodrug, Inc. (“Cascade”), a biotechnology company focused on advancing novel Hypoxia Activated Therapies in oncology, today announced the appointment of Manuel ( [...]
Kane Biotech Announces Second Quarter 2025 Financial Results
28/08/2025
WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its second quarter 2025 financial results. Second Quarter 2025 Financial [...]

Pages